Trending...
- MGTT Opens New U.S. Sales Office to Strengthen B2B Support for OEM ODM White Noise Sound Machines
- Award-winning NJ Author Celebrates New Release and Multi-Author Collaboration
- California: Governor Newsom proclaims Small Business Month 2025
The research study of this unique jellyfish collagen-based supplement was published in the peer-reviewed medical source, the Journal of Clinical Research and Reports.
TEMECULA, Calif. - Californer -- Jellyfish Publication-Certified Nutraceuticals, Inc.
Gerald M. Haase, M.D.
Clinical Professor of Surgery, University of Colorado School of Medicine, Aurora, CO.
Neil E. Wolkodoff, PhD
Medical Program Director, Colorado Center for Health and Sports Science, Denver, CO.
May 16, 2025
Certified Nutraceuticals, Inc., a research and product development enterprise in Pauma Valley, California, U.S.A., announces the publication of an exciting new human clinical trial of its proprietary KollaJell™ collagen peptide formulation.
The research study of this unique jellyfish collagen-based supplement was published in the peer-reviewed medical source, the Journal of Clinical Research and Reports. The strength of this prospective, randomized trial is the distinctive utilization of a panel of brain function metrics from two robust, validated instruments, including a computerized neurocognitive test battery and an electroencephalographic (EEG) profile of voltage activation and wave phase pattern. Instead of evaluating only one or two parameters, this investigation assessed seven domains of cognitive function in 23 subjects who consumed KollaJell™ for a period of eight weeks.
More on The Californer
The outcomes were clinically relevant, and all were statistically analyzed and achieved statistical significance. Standard scores matched for age and gender improved in all metrics regardless of the functional status of where the subject started. The parameters included compositive memory, neurocognitive index, visual memory, executive function and verbal memory. Under EEG monitoring conditions, the mean total reaction time and the trail-making composite test times also decreased dramatically. Topographic brain images showed voltage activation in the brain regions associated with sensory input and processing function. There were no adverse effects of consuming the supplement in any subject at any time during the study.
The importance of this pilot trial is the demonstration of a particularly extensive spectrum of beneficial results from the proprietary formulation compared to competing products that, even if helpful, provide only limited effects. In addition, the use of a marine-based natural collagen was superior to the usual animal-based products and the patented extraction process provided a greater platform of collagen types and a uniquely effective amino acid composition. This human clinical trial reinforces the concept that Certified Nutraceuticals KollaJell™ is a safe and beneficial collagen supplement that supports cognitive domains and memory and is applicable to a wide audience of potential consumers, regardless of their initial brain function status.
More on The Californer
The actual medical study is available as a free open-access publication at https://www.auctoresonline.org/article/effects-of-a-jellyfish-collagen-based-amino-acid-supplement-on-cognitive-function-and-memory-a-pilot-investigation
For further information about the product or study, please contact:
Sara Alkayali at (951) 600-3899 or email: salkayali@certifiednutra.com
Gerald M. Haase, M.D.
Clinical Professor of Surgery, University of Colorado School of Medicine, Aurora, CO.
Neil E. Wolkodoff, PhD
Medical Program Director, Colorado Center for Health and Sports Science, Denver, CO.
May 16, 2025
Certified Nutraceuticals, Inc., a research and product development enterprise in Pauma Valley, California, U.S.A., announces the publication of an exciting new human clinical trial of its proprietary KollaJell™ collagen peptide formulation.
The research study of this unique jellyfish collagen-based supplement was published in the peer-reviewed medical source, the Journal of Clinical Research and Reports. The strength of this prospective, randomized trial is the distinctive utilization of a panel of brain function metrics from two robust, validated instruments, including a computerized neurocognitive test battery and an electroencephalographic (EEG) profile of voltage activation and wave phase pattern. Instead of evaluating only one or two parameters, this investigation assessed seven domains of cognitive function in 23 subjects who consumed KollaJell™ for a period of eight weeks.
More on The Californer
- How Does Google Crawl Websites?
- A-One Janitorial Joins Urban Land Institute to Advance Sustainable Facility Practices
- Long Beach: City Seeks Local Businesses to Champion Youth Employment Opportunities
- Brensocatib Shows Consistent Efficacy and Safety Across Three Prespecified Subgroups in New Data from Landmark ASPEN Study
- Odyssey Charter Schools in Pasadena Run To Rebuild After Eaton Fire External Inbox
The outcomes were clinically relevant, and all were statistically analyzed and achieved statistical significance. Standard scores matched for age and gender improved in all metrics regardless of the functional status of where the subject started. The parameters included compositive memory, neurocognitive index, visual memory, executive function and verbal memory. Under EEG monitoring conditions, the mean total reaction time and the trail-making composite test times also decreased dramatically. Topographic brain images showed voltage activation in the brain regions associated with sensory input and processing function. There were no adverse effects of consuming the supplement in any subject at any time during the study.
The importance of this pilot trial is the demonstration of a particularly extensive spectrum of beneficial results from the proprietary formulation compared to competing products that, even if helpful, provide only limited effects. In addition, the use of a marine-based natural collagen was superior to the usual animal-based products and the patented extraction process provided a greater platform of collagen types and a uniquely effective amino acid composition. This human clinical trial reinforces the concept that Certified Nutraceuticals KollaJell™ is a safe and beneficial collagen supplement that supports cognitive domains and memory and is applicable to a wide audience of potential consumers, regardless of their initial brain function status.
More on The Californer
- Long Beach: Mark Twain Neighborhood Library to Undergo Energy Efficiency Upgrade
- WDBVC Celebrates Highest Ever Number of Graduates of High Road Construction Careers Program
- Compass Group Diversified Holdings (CODI) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- Sequentex Achieves OMNIA Partners Approval, Empowering Public Sector and other Agencies with Streamlined Technology Procurement
- CEO Selected to Present at Wall Street Conference on May 21, 2025 for Suicidal Depression / PTSD: NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)
The actual medical study is available as a free open-access publication at https://www.auctoresonline.org/article/effects-of-a-jellyfish-collagen-based-amino-acid-supplement-on-cognitive-function-and-memory-a-pilot-investigation
For further information about the product or study, please contact:
Sara Alkayali at (951) 600-3899 or email: salkayali@certifiednutra.com
Source: Certified Nutraceuticals, Inc.
0 Comments
Latest on The Californer
- Phoenix Implant Clinic Introduces Upfront Cost Page to Strengthen Patient Trust
- Pregis Expands its Curbside-Recyclable Paper Packaging Portfolio with White EasyPack GeoTerra
- Zeta Sky Empowers Southern California Businesses with Strategic IT Consulting and vCIO Services
- Advanced Dental Techniques Recognized as a Top Family Dentist for 2024
- Save 10 Percent on KeysCaribbean Vacation Home Rentals' Nightly Rate with 'Spring into Summer Sale'
- Cmo Council Member Survey Finds An Enduring And Engaged Community Of Marketing Unity Worldwide
- Solomon Eye Physicians & Surgeons announces appointment of Ann Reiling as Chief Operations Officer
- California: Largest ever multi-agency operation seizes $123.5 million in illicit cannabis
- KlearNow.AI Futurizes Tariff Compliance with Full Automation of Trump Tariff Determination
- Tamara Gurney Honored as Los Angeles Business Journal's Top 100 Banker - Small Business Advocate
- Governor Newsom: GOP bill would rip health care from up to 3.4 million Californians, cost the state billions, close hospitals and clinics
- Sumis Partners Launches, Uniting Industry Leaders to Redefine Life Sciences Consulting
- Appealing a Medicare Decision in Easy Steps
- DivX Launches Ultimate Guide to Free MP4 Playback
- Las Chorizeras Debut Self-Titled Release is An Instant Classic
- May Martin Jewelry Turns 11, Opens 4th Orange County Store
- Boston Industrial Solutions, Inc. introduces an advanced solvent for LSR silicone
- U.S. Lawmakers Propose New $250 Fee for Green Card Lottery Applicants
- OGN INVESTIGATION: Investigation Launched into Organon & Co. and Attorneys Encourage Investors with Substantial Losses or Witnesses with Relevant Information to Contact Firm
- NBA Legend Jeremy Lin, Benny Luo and Sy Huq Team Up to Executive Produce Powerful New Short Film "Ayo, Check Up!"